Petros Pharmaceuticals In... (PTPI)
0.30
-0.01 (-3.38%)
At close: Jan 15, 2025, 12:56 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -0.38 | -0.18 | -3.88 | -2.07 | -0.21 | -0.12 |
| PS Ratio | 0.53 | 0.80 | 4.64 | 4.47 | 0.44 | 0.28 |
| PB Ratio | 0.25 | 0.29 | 1.02 | 2.45 | 0.85 | -2.37 |
| P/FCF Ratio | -0.4 | -0.38 | -3.06 | -2.79 | 2.77 | 0.65 |
| P/OCF Ratio | -0.4 | -0.38 | -3.06 | -2.79 | 2.69 | 0.50 |
| OCF/S Ratio | -1.31 | -2.14 | -1.52 | -1.6 | 0.16 | 0.57 |
| Debt / Equity Ratio | 0.66 | 0.58 | 0.01 | 0.41 | 1.71 | -28.07 |
| Quick Ratio | 1.74 | 1.82 | 0.97 | 0.60 | 0.24 | 0.24 |
| Current Ratio | 1.89 | 2.08 | 0.99 | 0.62 | 0.29 | 0.41 |
| Asset Turnover | 0.17 | 0.18 | 0.12 | 0.14 | 0.27 | 0.21 |
| Interest Coverage | -25.4 | -26.59 | -48.96 | -5.66 | -1.22 | n/a |
| Return on Equity (ROE) | -0.65 | -1.62 | -0.26 | -1.18 | -4.05 | 19.31 |
| Return on Assets (ROA) | -0.24 | -0.83 | -0.14 | -0.29 | -0.56 | -0.49 |
| Return on Capital (ROIC) | -0.59 | -0.62 | -0.5 | -0.62 | -0.98 | -0.27 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 71.98% | 61.79% | 79.52% | 57.67% | 52.32% | 25.41% |
| Net Profit Margin | -140.2% | -451.22% | -119.77% | -215.35% | -208.71% | -231.1% |
| Pretax Profit Margin | -140.2% | -334.4% | -115.05% | -230.27% | -212.86% | -231.2% |
| Operating Profit Margin | -233.88% | -264.45% | -231.05% | -180.78% | -108.29% | -54.45% |
| FCF Margin | -130.99% | -213.57% | -151.86% | -160.15% | 15.80% | 43.73% |
| EBITDA Margin | -72.34% | -229.06% | -20.94% | -127.72% | -89.84% | 2.66% |